Home›Stock Screener›Medico Intercontinental›Financial Statements

Medico Intercontinental Complete Financial Statements

8 Years of Data
2025 - 2018

In FY2025, Medico Intercontinental (MIL) reported revenue ₹21 Cr, net profit ₹-5 Cr and EPS ₹-1.65, with a net profit margin of -23.8% and ROE of -10.2%. Full financial statements from FY2018 to FY2025 (8 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore MIL true value to estimate fundamental worth using multiple valuation models.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin -23.81% 2025 data
Operating Margin -4.00% 2025 data
Return on Assets -6.58% 2025 data
Return on Equity -10.20% 2025 data

Balance Sheet Ratios

Current Ratio 4.07 2025 data
Equity Ratio 64.47% 2025 data
Asset Turnover 0.28 2025 data

MIL Revenue, Net Profit & EBITDA — Year-on-Year Growth

MIL YoY (Sept 2024 vs Sept 2025) — revenue -43.2%, net profit -350.0%, EBITDA -100.0%, expenses -38.2%. Review Medico Intercontinental P/E valuation to evaluate earnings-based valuation against sector peers.

Revenue Growth
-43.2%
Year-over-Year
Net Profit Growth
-350.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-38.2%
Year-over-Year
Assets Growth
+35.7%
Year-over-Year
Equity Growth
+8.9%
Year-over-Year
Operating Cash Flow Growth
-216.7%
Year-over-Year
Investing Cash Flow Growth
+77.8%
Year-over-Year
Financing Cash Flow Growth
+1000.0%
Year-over-Year

MIL Income Statement — Revenue, EBITDA & Net Profit

Medico Intercontinental revenue ₹21 Cr, EBITDA ₹0 Cr, net profit ₹-5 Cr, EPS ₹-1.65 (2025) — net profit margin -23.8%. For live price, earnings ratios and company overview, see Medico Intercontinental share price chart.

Periods ₹ Crores
Particulars Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Mar 2023 Jun 2023 Dec 2023 Sept 2022 Mar 2022 Jun 2022 Dec 2022 Sept 2021 Mar 2021 Jun 2021 Dec 2021 Sept 2020 Mar 2020 Jun 2020 Dec 2020 Sept 2019 Mar 2019 Jun 2019 Dec 2019 Sept 2018 Jun 2018 Dec 2018
Revenue 21 21 22 20 37 16 19 19 17 29 24 14 16 15 13 18 19 15 24 18 19 19 20 16 22 9 18 23 0 0 1
Expenses 21 19 21 18 34 14 18 17 16 28 23 13 15 13 12 17 17 13 22 17 18 17 19 15 21 8 17 22 0 0 1
EBITDA 0 2 1 2 3 2 2 2 1 2 2 2 1 2 1 1 1 1 1 1 1 1 1 1 1 0 1 1 0 0 0
Operating Profit Margin % -4.00% 9.00% 3.00% 8.00% 7.00% 10.00% 8.00% 10.00% 8.00% 5.00% 6.00% 10.00% 9.00% 9.00% 11.00% 6.00% 7.00% 8.00% 6.00% 6.00% 6.00% 6.00% 6.00% 8.00% 5.00% 4.00% 5.00% 5.00% 96.00% 85.00% 19.00%
Depreciation 2 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 2 0 2 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -4 2 -2 -1 2 1 2 2 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 0 0 0
Tax 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit -5 1 -3 -2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 0 0 0
Earnings Per Share (₹) -1.65 1.17 -0.68 -0.22 1.63 1.04 1.08 1.17 0.87 1.01 1.02 1.02 2.66 2.67 2.65 0.94 2.29 1.74 2.28 2.30 2.09 1.79 2.05 2.05 1.78 0.81 1.80 1.90 0.54 0.46 0.53

MIL Balance Sheet — Assets, Liabilities & Shareholders' Equity

MIL total assets ₹76 Cr, total equity ₹49 Cr, total liabilities ₹ Cr (2025) — ROE -10.2%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018
ASSETS
Total Assets 76 56 59 32 31 36 9 4
Current Assets 57 39 50 28 28 34 8 2
Fixed Assets 9 4 3 2 2 2 0 0
Capital Work in Progress 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0
Other Assets 67 53 56 30 28 34 9 4
LIABILITIES
Total Liabilities
Current Liabilities 14 2 2 6 7 13 0 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 49 45 41 13 10 6 4 3
Share Capital 10 10 10 3 3 3 3 3
Reserves & Surplus 39 35 31 9 6 3 1 0

MIL Cash Flow Statement — Operating, Investing & Financing

Medico Intercontinental operating cash flow ₹-7 Cr, investing ₹-2 Cr, financing ₹9 Cr, net cash flow ₹-1 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018
Operating Activities -7 6 -10 4 6 -14 1 0
Investing Activities -2 -9 -5 -1 -1 0 0 0
Financing Activities 9 -1 20 -1 -5 13 0 0
Net Cash Flow -1 -3 5 1 0 0 1 0